精確搜索結(jié)果
- Products
- 內(nèi)容類型
- Analysis Platform
- 語言
- Publication Date
1 - 11 共 11 條結(jié)果
描述了 AdvanceBio SEC 200 ? 1.9 μm 色譜柱和其他供應商的 SEC 色譜柱之間在 mAb 和ADC 分析方面的比較。
| 日語 (日本) | 完整版（PDF） |
|---|
| 日語 (日本) | 完整版（PDF） |
|---|
The Agilent AdvanceBio SEC column together with the Agilent 1260 Infinity II Bio-inert System is an ideal combination for the aggregate analysis of ADCs
Fraction analysis of cysteine-linked antibody-drug conjugates using hydrophobic interaction chromatography on the Agilent 1260 Infinity II Bio-Inert LC system.
Size exclusion chromatography/mass spectrometry analysis of antibody drug conjugates using the Agilent 1260 Infinity II Bio-Inert LC
Identification of monoclonal antibody mutation sites using the 1290 Infinity II 2D-LC solution with 6530 Q-TOF LC/MS.
This application note demonstrates the drug-to-antibody (DAR) determination of brentuximab vedotin using a ternary gradient with the Agilent Infinity II Prime Bio LC.
This application note demonstrates the DAR determination of brentuximab vedotin using HIC.
Determination of drug to antibody ratio of brentuximab vedotin using hydrophobic interaction chromatography on the Agilent 1260 Infinity II Bio-inert LC
Methods using Agilent AdvanceBio SEC columns are developed for the characterization of components of standard protein mixtures.